Safety and efficacy of a novel drug elores (ceftriaxone + sulbactam + disodium edetate) in the management of multi-drug resistant bacterial infections in tertiary care centers: a post-marketing surveillance study-Reference-Cited by-同舟云学术

Safety and efficacy of a novel drug elores (ceftriaxone + sulbactam + disodium edetate) in the management of multi-drug resistant bacterial infections in tertiary care centers: a post-marketing surveillance study

Published:2017-07 Issue:4 Volume:21 Page:408-417
ISSN:1413-8670
Container-title:The Brazilian Journal of Infectious Diseases
language:en
Short-container-title:The Brazilian Journal of Infectious Diseases

Author:

Chaudhary Manu,Mir Mohd Amin,Ayub Shiekh Gazalla

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference30 articles.

1. Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America;Boucher;Clin Infect Dis,2009

2. Antimicrobial resistance: global report on surveillance 2014;WHO,2016

3. Estimating the length of hospitalization attributable to multidrug antibiotic resistance;Blot;Antimicrob Agents Chemother,2010

4. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America;Spellberg;Clin Infect Dis,2008

5. Current concepts in antimicrobial therapy against resistant Gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa;Kanj;Mayo Clin Proc,2011

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. β-Lactam potentiators to re-sensitize resistant pathogens: Discovery, development, clinical use and the way forward;Frontiers in Microbiology;2023-03-10

2. Evaluation of Ceftriaxone-Sulbactam-EDTA Adjuvant Combination against Multidrug Resistant Bacteria in Tertiary Care Hospital, Guntur, Andhra Pradesh, India;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2022

3. Metallo-β-Lactamases: Structure, Function, Epidemiology, Treatment Options, and the Development Pipeline;Antimicrobial Agents and Chemotherapy;2020-09-21

4. CSE (Ceftriaxone+ Sulbactam+ Disodium Edta): A Possible Solution to the Global Antimicrobial Resistance Pandemic;Journal of Pure and Applied Microbiology;2020-09-08

5. Ceftriaxone+Sulbactam+Disodium EDTA Versus Meropenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: PLEA, a Double-Blind, Randomized Noninferiority Trial;Open Forum Infectious Diseases;2019-08-21